WST vs COO — Key Metrics
| Metric | WST (WEST PHARMACEUTICAL SERVICES INC) | COO (COOPER COMPANIES INC) |
|---|---|---|
| Price | 370.76 | 56.53 |
| Market Cap | 26.09 Billion | 10.75 Billion |
| P/E (TTM) | 47.11 | 19.23 |
| P/B (Quarterly) | 8.366 | 1.449 |
| P/S (TTM) | 7.84 | 2.54 |
| Net Profit Margin (TTM) | 17.0 | 13.5 |
| Gross Margin (TTM) | 36.8 | 65.9 |
| ROE (TTM) | 18.5 | 6.9 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
WST · WEST PHARMACEUTICAL SERVICES INC
Greatly Underperform
COO · COOPER COMPANIES INC
Underperform
Recommendation Summary
Stock WST is projected to greatly underperform the market, stock COO is projected to underperform the market. Upfront Recommendation: COO.
Financial Metrics
Prices delayed ~15 min
| WST | Metrics | COO |
|---|---|---|
| $370.76 | Price | $56.53 |
| — | Market Capitalization | — |
| 47.11 | Price to Earnings Ratio | 19.23 |
| 7.84 | Price to Sales | 2.54 |
| 59.72 | Price to FCF Ratio | 15.85 |
| 21.32 | Price to Gross Profit | 3.85 |
| 350.71 | Price to R&D | 63.31 |
| 14.44 | Price to Current Assets | 4.71 |